Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell Transplant.
Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell Transplant. American journal of hematology Elmariah, H., Kim, J., Gonzalez, R., DiMaggio, E., Sansil, S., Mishra, A., Faramand, R., Perez, L., Lazaryan, A., Mirza, A., Khimani, F., Liu, H., Ochoa-Bayona, J. L., Nieder, M., Perna, F., Figura, N., Robinson, T. J., Nishihori, T., Anasetti, C., Pidala, J. A., Bejanyan, N. 2025View details for DOI 10.1002/ajh.27738
View details for PubMedID 40492500